» Articles » PMID: 10734042

The Akt Proto-oncogene Links Ras to Pak and Cell Survival Signals

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2000 Mar 29
PMID 10734042
Citations 75
Authors
Affiliations
Soon will be listed here.
Abstract

The Ras oncogene regulates cellular proliferation, differentiation, transformation, and survival through multiple downstream signals. Ras signals through its effector phosphoinositide 3 (PI3) kinase to the Pak protein kinase (p65(pak)), but the steps from Ras to Pak remain to be elucidated. PI3 kinase can stimulate the small G protein, Rac, a direct activator of Pak, as well as the Akt proto-oncogene, a serine-threonine protein kinase. We found that activated Akt stimulated Pak, whereas a dominant negative Akt inhibited Ras activation of Pak in transfection assays. Akt stimulation of Pak was not inhibited by dominant negative mutants of either Rac or Cdc42 suggesting that Akt activated Pak through a GTPase-independent mechanism. We also developed a novel cell-free system to study Ras activation of Pak. In this system Ras activated Pak only in the presence of a crude cell extract but failed to activate Pak when Akt was immunodepleted from the extract. Akt protects cells from apoptosis through phosphorylation of downstream targets such as the Bcl-2 family member, Bad. We found that activated Pak decreased apoptosis and increased phosphorylation of Bad, whereas dominant negative Pak increased apoptosis and decreased phosphorylation of Bad. These studies define a new oncogene-mediated cell survival signal.

Citing Articles

Nox1/PAK1 is required for angiotensin II-induced vascular inflammation and abdominal aortic aneurysm formation.

He H, Jiang T, Ding M, Zhu Y, Xu X, Huang Y Redox Biol. 2024; 79():103477.

PMID: 39721498 PMC: 11732235. DOI: 10.1016/j.redox.2024.103477.


ROS production by mitochondria: function or dysfunction?.

Palma F, Gantner B, Sakiyama M, Kayzuka C, Shukla S, Lacchini R Oncogene. 2023; 43(5):295-303.

PMID: 38081963 DOI: 10.1038/s41388-023-02907-z.


Pathophysiological impact of CXC and CX3CL1 chemokines in preeclampsia and gestational diabetes mellitus.

Ullah A, Zhao J, Singla R, Shen B Front Cell Dev Biol. 2023; 11:1272536.

PMID: 37928902 PMC: 10620730. DOI: 10.3389/fcell.2023.1272536.


PAK1 and Therapy Resistance in Melanoma.

Kichina J, Maslov A, Kandel E Cells. 2023; 12(19).

PMID: 37830586 PMC: 10572217. DOI: 10.3390/cells12192373.


YB-1 activating cascades as potential targets in KRAS-mutated tumors.

Khozooei S, Veerappan S, Toulany M Strahlenther Onkol. 2023; 199(12):1110-1127.

PMID: 37268766 DOI: 10.1007/s00066-023-02092-8.